⌘K

Login Start Free

Home/Filings/4/0000899243-22-034751

4//SEC Filing

BB BIOTECH AG 4

Accession 0000899243-22-034751

CIK 0001701541other

View on SEC.gov Company Profile

Filed

Nov 1, 8:00 PM ET

Accepted

Nov 2, 3:10 PM ET

Size

6.5 KB

Accession

0000899243-22-034751

Insider Transaction Report

Form 4

Period: 2022-10-31

Black Diamond Therapeutics, Inc.BDTX

BIOTECH GROWTH N V

10% Owner

Transactions

Purchase
Common Stock
2022-10-31$2.25/sh+99,801$224,912→ 5,377,839 total

10% Owner

Transactions

Purchase
Common Stock
2022-10-31$2.25/sh+99,801$224,912→ 5,377,839 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Black Diamond Therapeutics, Inc.

CIK 0001701541

Entity typeother

IncorporatedSwitzerland

Related Parties

1

filerCIK 0000924223

Filing Metadata

Form type: 4
Filed: Nov 1, 8:00 PM ET
Accepted: Nov 2, 3:10 PM ET
Size: 6.5 KB

View on SEC.gov